Escherichia, Shigella, andSalmonella

Nancy A. Strockbine; Cheryl A. Bopp; Patricia I. Fields; JAMES B. Kaper; James P. Nataro

doi:10.1128/9781555817381.ch37

Chapter 37 : Escherichia, Shigella, and Salmonella

Authors: Nancy A. Strockbine, Cheryl A. Bopp, Patricia I. Fields, JAMES B. Kaper, James P. Nataro

Content Type: Reference

Publication Year: 2015

Category: Clinical Microbiology

Book DOI: 10.1128/9781555817381

Chapter DOI: 10.1128/9781555817381.ch37

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Escherichia, Shigella, and Salmonella, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch37-1.gif /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch37-2.gif

There is no abstract provided for this chapter. We are in the process of generating a full text preview. Please bookmark and return later.

Citation: Strockbine N, Bopp C, Fields P, Kaper J, Nataro J. 2015. Escherichia, Shigella, and Salmonella, p 685-713. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch37

Highlighted Text: Show | Hide

Full text loading...

References

/content/book/10.1128/9781555817381.mcm11.ch37

1. Scheutz F,, Strockbine NA,. 2005. Genus I. Escherichia Castellani and Chalmers 1919, 941T AL, p 607–624. In Garrity GM,, Brenner DJ,, Krieg NR,, Staley JT ( ed), Bergey’s Manual of Systematic Bacteriology, 2nd ed, vol 2, part B. Springer-Verlag, New York, NY.

2. Ewing WH. 1986. Edwards and Ewing’s Identification of Enterobacteriaceae, 4th ed. Elsevier Scientific Publishing Co, Inc, New York, NY.

3. Brenner DJ,, Farmer JJI,. 2005. Order XIII. “ Enterobacteriales,” p 587–607. In Garrity GM,, Brenner DJ,, Krieg NR,, Staley JT ( ed), Bergey’s Manual of Systematic Bacteriology, 2nd ed, vol 2, part B. Springer-Verlag, New York, NY.

4. Brenner DJ,. 1992. Introduction to the family Enterobacteriaceae, p 2673–2695. In Balows A,, Truper HG,, Dworkin M,, Harder W,, Schleifer KH ( ed), The Prokaryotes, 2nd ed. Springer-Verlag KG, Berlin, Germany.

5. Castellani A,, Chalmers AJ. 1919. Manual of Tropical Medicine, 3rd ed. William Wood and Company, New York, NY.

6. Priest FG,, Barker M. Gram-negative bacteria associated with brewery yeasts: reclassification of Obesumbacterium proteus biogroup 2 as Shimwellia pseudoproteus gen. nov., sp. nov., and transfer of Escherichia blattae to Shimwellia blattae comb. nov. Int J Syst Evol Microbiol 60: 828– 833.

7. Goris J,, Konstantinidis KT,, Klappenbach JA,, Coenye T,, Vandamme P,, Tiedje JM. 2007. DNA-DNA hybridization values and their relationship to whole-genome sequence similarities. Int J Syst Evol Microbiol 57: 81– 91.

8. Hyma KE,, Lacher DW,, Nelson AM,, Bumbaugh AC,, Janda JM,, Strockbine NA,, Young VB,, Whittam TS. 2005. Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains. J Bacteriol 187: 619– 628.

9. Dobrindt U,, Agerer F,, Michaelis K,, Janka A,, Buchrieser C,, Samuelson M,, Svanborg C,, Gottschalk G,, Karch H,, Hacker J. 2003. Analysis of genome plasticity in pathogenic and commensal Escherichia coli isolates by use of DNA arrays. J Bacteriol 185: 1831– 1840.

10. Ogura Y,, Ooka T,, Asadulghani Terajima J,, Nougayrede JP,, Kurokawa K,, Tashiro K,, Tobe T,, Nakayama K,, Kuhara S,, Oswald E,, Watanabe H,, Hayashi T. 2007. Extensive genomic diversity and selective conservation of virulence-determinants in enterohemorrhagic Escherichia coli strains of O157 and non-O157 serotypes. Genome Biol 8: R138. doi:10.1186/gb-2007–8-7-r138.

11. Rasko DA,, Rosovitz MJ,, Myers GS,, Mongodin EF,, Fricke WF,, Gajer P,, Crabtree J,, Sebaihia M,, Thomson NR,, Chaudhuri R,, Henderson IR,, Sperandio V,, Ravel J. 2008. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J Bacteriol 190: 6881– 6893.

12. Chaudhuri RR,, Sebaihia M,, Hobman JL,, Webber MA,, Leyton DL,, Goldberg MD,, Cunningham AF,, Scott-Tucker A,, Ferguson PR,, Thomas CM,, Frankel G,, Tang CM,, Dudley EG,, Roberts IS,, Rasko DA,, Pallen MJ,, Parkhill J,, Nataro JP,, Thomson NR,, Henderson IR. Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. PLoS One 5: e8801. 10.1371/journal.pone.0008801.

13. Abu-Ali GS,, Lacher DW,, Wick LM,, Qi W,, Whittam TS. 2009. Genomic diversity of pathogenic Escherichia coli of the EHEC 2 clonal complex. BMC Genomics 10: 296. 10.1186/1471-2164-10-296.

14. Blattner FR,, Plunkett G, III,, Bloch CA,, Perna NT,, Burland V,, Riley M,, Collado-Vides J,, Glasner JD,, Rode CK,, Mayhew GF,, Gregor J,, Davis NW,, Kirkpatrick HA,, Goeden MA,, Rose DJ,, Mau B,, Shao Y. 1997. The complete genome sequence of Escherichia coli K-12. Science 277: 1453– 1462.

15. Kaas RS,, Friis C,, Ussery DW,, Aarestrup FM. 2012. Estimating variation within the genes and inferring the phylogeny of 186 sequenced diverse Escherichia coli genomes. BMC Genomics 13: 577. doi:10.1186/1471-2164-13-577.

16. Rasko DA,, Rosovitz MJ,, Myers GS,, Mongodin EF,, Fricke WF,, Gajer P,, Crabtree J,, Sebaihia M,, Thomson NR,, Chaudhuri R,, Henderson IR,, Sperandio V,, Ravel J. 2008. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J Bacteriol 190: 6881– 6893.

17. Johnson TJ,, Nolan LK. 2009. Pathogenomics of the virulence plasmids of Escherichia coli. Microbiol Mol Biol Rev 73: 750– 774.

18. Herold S,, Karch H,, Schmidt H. 2004. Shiga toxin-encoding bacteriophages—genomes in motion. Int J Med Microbiol 294: 115– 121.

19. Asadulghani M,, Ogura Y,, Ooka T,, Itoh T,, Sawaguchi A,, Iguchi A,, Nakayama K,, Hayashi T. 2009. The defective prophage pool of Escherichia coli O157: prophage-prophage interactions potentiate horizontal transfer of virulence determinants. PLoS Pathog 5: e1000408. 10.1371/journal.ppat.1000408.

20. Hayashi T,, Makino K,, Ohnishi M,, Kurokawa K,, Ishii K,, Yokoyama K,, Han CG,, Ohtsubo E,, Nakayama K,, Murata T,, Tanaka M,, Tobe T,, Iida T,, Takami H,, Honda T,, Sasakawa C,, Ogasawara N,, Yasunaga T,, Kuhara S,, Shiba T,, Hattori M,, Shinagawa H. 2001. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res 8: 11– 22.

21. Ohnishi M,, Kurokawa K,, Hayashi T. 2001. Diversification of Escherichia coli genomes: are bacteriophages the major contributors? Trends Microbiol 9: 481– 485.

22. Bielaszewska M,, Kock R,, Friedrich AW,, von Eiff C,, Zimmerhackl LB,, Karch H,, Mellmann A. 2007. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS One 2: e1024. 10 .1371/journal.pone.0001024.

23. Bielaszewska M,, Middendorf B,, Kock R,, Friedrich AW,, Fruth A,, Karch H,, Schmidt MA,, Mellmann A. 2008. Shiga toxin–negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution. Clin Infect Dis 47: 208– 217.

24. Teunis PF,, Ogden ID,, Strachan NJ. 2008. Hierarchical dose response of E. coli O157:H7 from human outbreaks incorporating heterogeneity in exposure. Epidemiol Infect 136: 761– 770.

25. Porter CK,, Riddle MS,, Tribble DR,, Louis Bougeois A,, McKenzie R,, Isidean SD,, Sebeny P,, Savarino SJ. 2011. A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC). Vaccine 29: 5869– 5885.

26. Awsare SV,, Lillo M. 1991. A case report of Escherichia vulneris urosepsis. Rev Infect Dis 13: 1247– 1248.

27. Brenner DJ,, McWhorter AC,, Knutson JK,, Steigerwalt AG. 1982. Escherichia vulneris: a new species of Enterobacteriaceae associated with human wounds. J Clin Microbiol 15: 1133– 1140.

28. Farmer JJ, III,, Fanning GR,, Davis BR,, O’Hara CM,, Riddle C,, Hickman-Brenner FW,, Asbury MA,, Lowery VA, III,, Brenner DJ. 1985. Escherichia fergusonii and Enterobacter taylorae, two new species of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol 21: 77– 81.

29. Pien FD,, Shrum S,, Swenson JM,, Hill BC,, Thornsberry C,, Farmer JJ, III. 1985. Colonization of human wounds by Escherichia vulneris and Escherichia hermannii. J Clin Microbiol 22: 283– 285.

30. Huys G,, Cnockaert M,, Janda JM,, Swings J. 2003. Escherichia albertii sp. nov., a diarrhoeagenic species isolated from stool specimens of Bangladeshi children. Int J Syst Evol Microbiol 53: 807– 810.

31. Levine WN,, Goldberg MJ. 1994. Escherichia vulneris osteomyelitis of the tibia caused by a wooden foreign body. Orthop Rev 23: 262– 265.

32. Senanayake SN,, Jadeer A,, Talaulikar GS,, Roy J. 2006. First reported case of dialysis-related peritonitis due to Escherichia vulneris. J Clin Microbiol 44: 4283– 4284.

33. Bangert RL,, Ward AC,, Stauber EH,, Cho BR,, Widders PR. 1988. A survey of the aerobic bacteria in the feces of captive raptors. Avian Dis 32: 53– 62.

34. Oaks JL,, Besser TE,, Walk ST,, Gordon DM,, Beckmen KB,, Burek KA,, Haldorson GJ,, Bradway DS,, Ouellette L,, Rurangirwa FR,, Davis MA,, Dobbin G,, Whittam TS. 2010. Escherichia albertii in wild and domestic birds. Emerg Infect Dis 16: 638– 646.

35. Doi Y,, Paterson DL,, Egea P,, Pascual A,, Lopez-Cerero L,, Navarro MD,, Adams-Haduch JM,, Qureshi ZA,, Sidjabat HE,, Rodriguez-Bano J. Extended-spectrum and CMY-type β-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin Microbiol Infect 16: 33– 38.

36. Muresu R,, Maddau G,, Delogu G,, Cappuccinelli P,, Squartini A. 2010. Bacteria colonizing root nodules of wild legumes exhibit virulence-associated properties of mammalian pathogens. Antonie Van Leeuwenhoek 97: 143– 153.

37. Hurrell E,, Kucerova E,, Loughlin M,, Caubilla-Barron J,, Hilton A,, Armstrong R,, Smith C,, Grant J,, Shoo S,, Forsythe S. 2009. Neonatal enteral feeding tubes as loci for colonisation by members of the Enterobacteriaceae. BMC Infect Dis 9: 146. doi:10.1186/1471-2334-9-146.

38. Stock I,, Rahman M,, Sherwood KJ,, Wiedemann B. 2005. Natural antimicrobial susceptibility patterns and biochemical identification of Escherichia albertii and Hafnia alvei strains. Diagn Microbiol Infect Dis 51: 151– 163.

39. Ooka T,, Tokuoka E,, Furukawa M,, Nagamura T,, Ogura Y,, Arisawa K,, Harada S,, Hayashi T. 2013. Human gastroenteritis outbreak associated with Escherichia albertii, Japan. Emerg Infect Dis 19: 144– 146.

40. Petty NK,, Ben Zakour NL,, Stanton-Cook M,, Skippington E,, Totsika M,, Forde BM,, Phan MD,, Gomes Moriel D,, Peters KM,, Davies M,, Rogers BA,, Dougan G,, Rodriguez-Bano J,, Pascual A,, Pitout JD,, Upton M,, Paterson DL,, Walsh TR,, Schembri MA,, Beatson SA. 2014. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A 111: 5694– 5699.

41. Croxen MA,, Finlay BB. 2010. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 8: 26– 38.

42. Johnson JR,, Russo TA. 2005. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol 295: 383– 404.

43. Kaper JB,, Nataro JP,, Mobley HL. 2004. Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123– 140.

44. Dietzman DE,, Fischer GW,, Schoenknecht FD. 1974. Neonatal Escherichia coli septicemia—bacterial counts in blood. J Pediatr 85: 128– 130.

45. Kim BY,, Kang J,, Kim KS. 2005. Invasion processes of pathogenic Escherichia coli. Int J Med Microbiol 295: 463– 470.

46. Nataro JP,, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142– 201.

47. Scallan E,, Hoekstra RM,, Angulo FJ,, Tauxe RV,, Widdowson MA,, Roy SL,, Jones JL,, Griffin PM. 2011. Food borne illness acquired in the United States—major pathogens. Emerg Infect Dis 17: 7– 15.

48. Griffin PM,, Mead PS,, Sivapalasingam S,. 2002. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli, p 627– 642. In Blaser MJ,, Smith PD,, Ravdin JI,, Greenberg HB,, Guerrant RL ( ed), Infections of the Gastrointestinal Tract, 2nd ed. Lippincott Williams & Wilkins, Philadelphia, PA.

49. Rangel JM,, Sparling PH,, Crowe C,, Griffin PM,, Swerdlow DL. 2005. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982–2002. Emerg Infect Dis 11: 603– 609.

50. Hoefer D,, Hurd S,, Medus C,, Cronquist A,, Hanna S,, Hatch J,, Hayes T,, Larson K,, Nicholson C,, Wymore K,, Tobin-D’Angelo M,, Strockbine N,, Snippes P,, Atkinson R,, Griffin PM,, Gould LH, Emerging Infections Program FoodNet Working Group . 2011. Laboratory practices for the identification of Shiga toxin–producing Escherichia coli in the United States, FoodNet sites, 2007. Foodborne Pathog Dis 8: 555– 560.

51. Slutsker L,, Ries AA,, Greene KD,, Wells JG,, Hutwagner L,, Griffin PM. 1997. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 126: 505– 513.

52. Miko A,, Delannoy S,, Fach P,, Strockbine NA,, Lindstedt BA,, Mariani-Kurkdjian P,, Reetz J,, Beutin L. 2013. Genotypes and virulence characteristics of Shiga toxin-producing Escherichia coli O104 strains from different origins and sources. Int J Med Microbiol 303: 410– 421.

53. Brooks JT,, Sowers EG,, Wells JG,, Greene KD,, Griffin PM,, Hoekstra RM,, Strockbine NA. 2005. Non-O157 Shiga toxin–producing Escherichia coli infections in the United States, 1983–2002. J Infect Dis 192: 1422– 1429.

54. Gould LH,, Mody RK,, Ong KL,, Clogher P,, Cronquist AB,, Garman KN,, Lathrop S,, Medus C,, Spina NL,, Webb TH,, White PL,, Wymore K,, Gierke RE,, Mahon BE,, Griffin PM, Emerging Infections Program FoodNet Working Group . 2013. Increased recognition of non-O157 Shiga toxin–producing Escherichia coli infections in the United States during 2000–2010: epidemiologic features and comparison with E. coli O157 infections. Foodborne Pathog Dis 10: 453– 460.

55. Dalton CB,, Mintz ED,, Wells JG,, Bopp CA,, Tauxe RV. 1999. Outbreaks of enterotoxigenic Escherichia coli infection in American adults: a clinical and epidemiologic profile. Epidemiol Infect 123: 9– 16.

56. Yoder JS,, Cesario S,, Plotkin V,, Ma X,, Kelly-Shannon K,, Dworkin MS. 2006. Outbreak of enterotoxigenic Escherichia coli infection with an unusually long duration of illness. Clin Infect Dis 42: 1513– 1517.

57. Vial PA,, Mathewson JJ,, DuPont HL,, Guers L,, Levine MM. 1990. Comparison of two assay methods for patterns of adherence to HEp-2 cells of Escherichia coli from patients with diarrhea. J Clin Microbiol 28: 882– 885.

58. Donnenberg MS,. 2002. Enteropathogenic Escherichia coli, p 595–612. In Blaser MJ,, Smith PD,, Ravdin JI,, Greenberg HB,, Guerrant RL ( ed), Infections of the Gastrointestinal Tract, 2nd ed. Lippincott Williams & Wilkins, Philadelphia, PA.

59. Hedberg CW,, Savarino SJ,, Besser JM,, Paulus CJ,, Thelen VM,, Myers LJ,, Cameron DN,, Barrett TJ,, Kaper JB,, Osterholm MT. 1997. An outbreak of foodborne illness caused by Escherichia coli O39:NM, an agent not fitting into the existing scheme for classifying diarrheogenic E. coli. J Infect Dis 176: 1625– 1628.

60. Trabulsi LR,, Keller R,, Tardelli Gomes TA. 2002. Typical and atypical enteropathogenic Escherichia coli. Emerg Infect Dis 8: 508– 513.

61. Escher M,, Scavia G,, Morabito S,, Tozzoli R,, Maugliani A,, Cantoni S,, Fracchia S,, Bettati A,, Casa R,, Gesu GP,, Torresani E,, Caprioli A. 2014. A severe foodborne outbreak of diarrhoea linked to a canteen in Italy caused by enteroinvasive Escherichia coli, an uncommon agent. Epidemiol Infect 10.1017/S0950268814000181.

62. Huang DB,, Koo H,, DuPont HL. 2004. Enteroaggregative Escherichia coli: an emerging pathogen. Curr Infect Dis Rep 6: 83– 86.

63. Nataro JP,, Deng Y,, Cookson S,, Cravioto A,, Savarino SJ,, Guers LD,, Levine MM,, Tacket CO. 1995. Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers. J Infect Dis 171: 465– 468.

64. Cobeljic M,, Miljkovic-Selimovic B,, Paunovic-Todosijevic D,, Velickovic Z,, Lepsanovic Z,, Zec N,, Savic D,, Ilic R,, Konstantinovic S,, Jovanovic B,, Kostic V. 1996. Enteroaggregative Escherichia coli associated with an outbreak of diarrhoea in a neonatal nursery ward. Epidemiol Infect 117: 11– 16.

65. Cohen MB,, Nataro JP,, Bernstein DI,, Hawkins J,, Roberts N,, Staat MA. 2005. Prevalence of diarrheagenic Escherichia coli in acute childhood enteritis: a prospective controlled study. J Pediatr 146: 54– 61.

66. Sarantuya J,, Nishi J,, Wakimoto N,, Erdene S,, Nataro JP,, Sheikh J,, Iwashita M,, Manago K,, Tokuda K,, Yoshinaga M,, Miyata K,, Kawano Y. 2004. Typical enteroaggregative Escherichia coli is the most prevalent pathotype among E. coli strains causing diarrhea in Mongolian children. J Clin Microbiol 42: 133– 139.

67. Muniesa M,, Hammerl JA,, Hertwig S,, Appel B,, Brussow H. 2012. Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology. Appl Environ Microbiol 78: 4065– 4073.

68. Tacket CO,, Moseley SL,, Kay B,, Losonsky G,, Levine MM. 1990. Challenge studies in volunteers using Escherichia coli strains with diffuse adherence to HEp-2 cells. J Infect Dis 162: 550– 552.

69. Levine MM,, Ferreccio C,, Prado V,, Cayazzo M,, Abrego P,, Martinez J,, Maggi L,, Baldini MM,, Martin W,, Maneval D,, Kay B,, Guers L,, Lior H,, Wasserman SS,, Nataro JP. 1993. Epidemiologic studies of Escherichia coli diarrheal infections in a low socioeconomic level peri-urban community in Santiago, Chile. Am J Epidemiol 138: 849– 869.

70. Servin AL. 2005. Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clin Microbiol Rev 18: 264– 292.

71. Caprioli A,, Falbo V,, Roda LG,, Ruggeri FM,, Zona C. 1983. Partial purification and characterization of an Escherichia coli toxic factor that induces morphological cell alterations. Infect Immun 39: 1300– 1306.

72. Blanco JE,, Blanco J,, Blanco M,, Alonso MP,, Jansen WH. 1994. Serotypes of CNF1-producing Escherichia coli strains that cause extraintestinal infections in humans. Eur J Epidemiol 10: 707– 711.

73. Oswald E,, De Rycke J,, Guillot JF,, Boivin R. 1989. Cytotoxic effect of multinucleation in HeLa cell cultures associated with the presence of Vir plasmid in Escherichia coli strains. FEMS Microbiol Lett 49: 95– 99.

74. Smith HW. 1974. A search for transmissible pathogenic characters in invasive strains of Escherichia coli: the discovery of a plasmid-controlled lethal character closely associated, or identical, with colicine V. J Gen Microbiol 83: 95– 111.

75. De Rycke J,, Guillot JF,, Boivin R. 1997. Cytotoxins in nonenterotoxigenic strains of Escherichia coli isolated from feces of diarrheic calves. Vet Microbiol 15: 137– 150.

76. Johnson WM,, Lior H. 1988. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb Pathog 4: 103– 113.

77. Albert MJ,, Faruque SM,, Faruque AS,, Bettelheim KA,, Neogi PK,, Bhuiyan NA,, Kaper JB. 1996. Controlled study of cytolethal distending toxin-producing Escherichia coli infections in Bangladeshi children. J Clin Microbiol 34: 717– 719.

78. McVeigh A,, Fasano A,, Scott DA,, Jelacic S,, Moseley SL,, Robertson DC,, Savarino SJ. 2000. IS 1414, an Escherichia coli insertion sequence with a heat-stable enterotoxin gene embedded in a transposase-like gene. Infect Immun 68: 5710– 5715.

79. Adkins HJ,, Santiago LT. 1987. Increased recovery of enteric pathogens by use of both stool and rectal swab specimens. J Clin Microbiol 25: 158– 159.

80. Hardy AV,, Mackel D,, Frazier D,, Hamerick D. 1953. The relative efficacy of cultures for Shigella. U S Amed Forces Med J 4: 393– 394.

81. Stuart RD. 1959. Transport medium for specimens in public health bacteriology. Public Health Rep 74: 431– 438.

82. Ethelberg S,, Olsen KE,, Gerner-Smidt P,, Molbak K. 2007. The significance of the number of submitted samples and patient-related factors for faecal bacterial diagnostics. Clin Microbiol Infect 13: 1095– 1099.

83. Wells JG,, Morris GK. 1981. Evaluation of transport methods for isolating Shigella spp. J Clin Microbiol 13: 789– 790.

84. Gilligan PH,, Janda JM,, Karmali MA,, Miller JM,. 1992. Cumitech 12A: Laboratory Diagnosis of Bacterial Diarrhea. Coordinating ed, Nolte FS. ASM Press, Washington, DC.

85. Wang WL,, Reller LB,, Smallwood B,, Luechtefeld NW,, Blaser MJ. 1983. Evaluation of transport media for Campylobacter jejuni in human fecal specimens. J Clin Microbiol 18: 803– 807.

86. DeWitt WE,, Gangarosa EJ,, Huq I,, Zarifi A. 1971. Holding media for the transport of Vibrio cholerae from field to laboratory. Am J Trop Med Hyg 20: 685– 688.

87. Mackenzie AM,, Lebel P,, Orrbine E,, Rowe PC,, Hyde L,, Chan F,, Johnson W,, McLaine PN,, The SYNSORB Pk Study investigators. 1998. Sensitivities and specificities of Premier E. coli O157 and Premier EHEC enzyme immunoassays for diagnosis of infection with verotoxin (Shiga-like toxin)-producing Escherichia coli. J Clin Microbiol 36: 1608– 1611.

88. Park CH,, Kim HJ,, Hixon DL,, Bubert A. 2003. Evaluation of the duopath verotoxin test for detection of Shiga toxins in cultures of human stools. J Clin Microbiol 41: 2650– 2653.

89. Claas EC,, Burnham CA,, Mazzulli T,, Templeton K,, Topin F. 2013. Performance of the xTAG® gastrointestinal pathogen panel, a multiplex molecular assay for simultaneous detection of bacterial, viral, and parasitic causes of infectious gastroenteritis. J Microbiol Biotechnol 23: 1041– 1045.

90. Navidad JF,, Griswold DJ,, Gradus MS,, Bhattacharyya S. 2013. Evaluation of Luminex xTAG gastrointestinal pathogen analyte-specific reagents for high-throughput, simultaneous detection of bacteria, viruses, and parasites of clinical and public health importance. J Clin Microbiol 51: 3018– 3024.

91. Buchan BW,, Olson WJ,, Pezewski M,, Marcon MJ,, Novicki T,, Uphoff TS,, Chandramohan L,, Revell P,, Ledeboer NA. 2013. Clinical evaluation of a real-time PCR assay for the identification of Salmonella, Shigella, Campylobacter ( Campylobacter jejuni and C. coli), and Shiga toxin-producing E. coli in stool specimens. J Clin Microbiol 51: 4001– 4007.

92. Wessels E,, Rusman LG,, van Bussel MJ,, Claas EC. 2013. Added value of multiplex Luminex Gastrointestinal Pathogen Panel (xTAG® GPP) testing in the diagnosis of infectious gastroenteritis. Clin Microbiol Infect 20: O182– O187.

93. Gould LH,, Bopp C,, Strockbine N,, Atkinson R,, Baselski V,, Body B,, Carey R,, Crandall C,, Hurd S,, Kaplan R,, Neill M,, Shea S,, Somsel P,, Toben-D’Angelo M,, Griffin P,, Gerner-Smidt P, Centers for Disease Control and Prevention (CDC) . 2009. Recommendations for diagnosis of Shiga toxin–producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep 58: 1– 14.

94. Aspevall O,, Osterman B,, Dittmer R,, Sten L,, Lindback E,, Forsum U. 2002. Performance of four chromogenic urine culture media after one or two days of incubation compared with reference media. J Clin Microbiol 40: 1500– 1503.

95. Chaux C,, Crepy M,, Xueref S,, Roure C,, Gille Y,, Freydiere AM. 2002. Comparison of three chromogenic agar plates for isolation and identification of urinary tract pathogens. Clin Microbiol Infect 8: 641– 645.

96. Johnson KE,, Thorpe CM,, Sears CL. 2006. The emerging clinical importance of non-O157 Shiga toxin–producing Escherichia coli. Clin Infect Dis 43: 1587– 1595.

97. Kehl KS,, Havens P,, Behnke CE,, Acheson DW. 1997. Evaluation of the Premier EHEC assay for detection of Shiga toxin-producing Escherichia coli. J Clin Microbiol 35: 2051– 2054.

98. Manning SD,, Madera RT,, Schneider W,, Dietrich SE,, Khalife W,, Brown W,, Whittam TS,, Somsel P,, Rudrik JT. 2007. Surveillance for Shiga toxin–producing Escherichia coli, Michigan, 2001–2005. Emerg Infect Dis 13: 318– 321.

99. Paton AW,, Paton JC. 1998. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfb O111, and rfb O157. J Clin Microbiol 36: 598– 602.

100. Gavin PJ,, Peterson LR,, Pasquariello AC,, Blackburn J,, Hamming MG,, Kuo KJ,, Thomson RB, Jr. 2004. Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli Microplate assay for detection of Shiga toxin-producing E. coli in stool samples. J Clin Microbiol 42: 1652– 1656.

101. Tarr PI,, Gordon CA,, Chandler WL. 2005. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073– 1086.

102. van Duynhoven YT,, Friesema IH,, Schuurman T,, Roovers A,, van Zwet AA,, Sabbe LJ,, van der Zwaluw WK,, Notermans DW,, Mulder B,, van Hannen EJ,, Heilmann FG,, Buiting A,, Jansen R,, Kooistra-Smid AM. 2008. Prevalence, characterisation and clinical profiles of Shiga toxin-producing Escherichia coli in The Netherlands. Clin Microbiol Infect 14: 437– 445.

103. Brooks JT,, Sowers EG,, Wells JG,, Greene KD,, Griffin PM,, Hoekstra RM,, Strockbine NA. 2005. Non-O157 Shiga toxin–producing Escherichia coli infections in the United States, 1983–2002. J Infect Dis 192: 1422– 1429.

104. Centers for Disease Control and Prevention . 2006. FoodNet Surveillance Report for 2004 (Final Report). CDC, Atlanta, GA. http://www.cdc.gov/foodnet/PDFs/Report.pdf.

105. Guerrant RL,, Van Gilder TJ,, Steiner TS,, Thielman NM,, Slutsker L,, Tauxe RV,, Hennessy TW,, Griffin PM,, DuPont H,, Sack B,, Tarr PI,, Neill MA,, Nachamkin I,, Reller B,, Osterholm MT,, Bennish ML,, Pickering LK. 2001. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 32: 331– 350.

106. Karch H,, Janetzki-Mittmann C,, Aleksic S,, Datz M. 1996. Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture. J Clin Microbiol 34: 516– 519.

107. Paton AW,, Ratcliff RM,, Doyle RM,, Seymour-Murray J,, Davos D,, Lanser JA,, Paton JC. 1996. Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli. J Clin Microbiol 34: 1622– 1627.

108. March SB,, Ratnam S. 1986. Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol 23: 869– 872.

109. Bitzan M,, Ludwig K,, Klemt M,, Konig H,, Buren J,, Muller-Wiefel DE. 1993. The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study. Epidemiol Infect 110: 183– 196.

110. Church DL,, Emshey D,, Semeniuk H,, Lloyd T,, Pitout JD. 2007. Evaluation of BBL CHROMagar O157 versus sorbitol-MacConkey medium for routine detection of Escherichia coli O157 in a centralized regional clinical microbiology laboratory. J Clin Microbiol 45: 3098– 3100.

111. Bettelheim KA. 2005. Reliability of O157:H7 ID agar (O157 H7 ID-F) for the detection and isolation of verocytotoxigenic strains of Escherichia coli belonging to serogroup O157. J Appl Microbiol 99: 408– 410.

112. Manafi M,, Kremsmaier B. 2001. Comparative evaluation of different chromogenic/fluorogenic media for detecting Escherichia coli O157:H7 in food. Int J Food Microbiol 71: 257– 262.

113. Novicki TJ,, Daly JA,, Mottice SL,, Carroll KC. 2000. Comparison of sorbitol MacConkey agar and a two-step method which utilizes enzyme-linked immunosorbent assay toxin testing and a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coli. J Clin Microbiol 38: 547– 551.

114. Wylie JL,, Van Caeseele P,, Gilmour MW,, Sitter D,, Guttek C,, Giercke S. 2013. Evaluation of a new chromogenic agar medium for detection of Shiga toxin-producing Escherichia coli (STEC) and relative prevalences of O157 and non-O157 STEC in Manitoba, Canada. J Clin Microbiol 51: 466– 471.

115. Sowers EG,, Wells JG,, Strockbine NA. 1996. Evaluation of commercial latex reagents for identification of O157 and H7 antigens of Escherichia coli. J Clin Microbiol 34: 1286– 1289.

116. Borczyk AA,, Harnett N,, Lombos M,, Lior H. 1990. False-positive identification of Escherichia coli O157 by commercial latex agglutination tests. Lancet 336: 946– 947.

117. Scotland SM,, Cheasty T,, Thomas A,, Rowe B. 1991. Beta-glucuronidase activity of Vero cytotoxin-producing strains of Escherichia coli, including serogroup O157, isolated in the United Kingdom. Lett Appl Microbiol 13: 42– 44.

118. Hayes PS,, Blom K,, Feng P,, Lewis J,, Strockbine NA,, Swaminathan B. 1995. Isolation and characterization of a β- D-glucuronidase-producing strain of Escherichia coli serotype O157:H7 in the United States. J Clin Microbiol 33: 3347– 3348.

119. Beutin L,, Montenegro MA,, Orskov I,, Orskov F,, Prada J,, Zimmermann S,, Stephan R. 1989. Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli. J Clin Microbiol 27: 2559– 2564.

120. Sugiyama K,, Inoue K,, Sakazaki R. 2001. Mitomycin-supplemented washed blood agar for the isolation of Shiga toxin-producing Escherichia coli other than O157:H7. Lett Appl Microbiol 33: 193– 195.

121. Schmidt H,, Karch H. 1996. Enterohemolytic phenotypes and genotypes of Shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol 34: 2364– 2367.

122. O’Hara CM. 2006. Evaluation of the Phoenix 100 ID/AST system and NID panel for identification of Enterobacteriaceae, Vibrionaceae, and commonly isolated nonenteric gram-negative bacilli. J Clin Microbiol 44: 928– 933.

123. O’Hara CM,, Miller JM. 2003. Evaluation of the Vitek 2 ID-GNB assay for identification of members of the family Enterobacteriaceae and other nonenteric gram-negative bacilli and comparison with the Vitek GNI+ card. J Clin Microbiol 41: 2096– 2101.

124. O’Hara CM,, Miller JM. 2000. Evaluation of the MicroScan Rapid Neg ID3 panel for identification of Enterobacteriaceae and some common gram-negative nonfermenters. J Clin Microbiol 38: 3577– 3580.

125. Abbott SL,, O’Connor J,, Robin T,, Zimmer BL,, Janda JM. 2003. Biochemical properties of a newly described Escherichia species, Escherichia albertii. J Clin Microbiol 41: 4852– 4854.

126. He Y,, Li H,, Lu X,, Stratton CW,, Tang YW. 2010. Mass spectrometry biotyper system identifies enteric bacterial pathogens directly from colonies grown on selective stool culture media. J Clin Microbiol 48: 3888– 3892.

127. Dubois D,, Grare M,, Prere MF,, Segonds C,, Marty N,, Oswald E. 2012. Performances of the Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry system for rapid identification of bacteria in routine clinical microbiology. J Clin Microbiol 50: 2568– 2576.

128. Clark CG,, Kruczkiewicz P,, Guan C,, McCorrister SJ,, Chong P,, Wylie J,, van Caeseele P,, Tabor HA,, Snarr P,, Gilmour MW,, Taboada EN,, Westmacott GR. 2013. Evaluation of MALDI-TOF mass spectroscopy methods for determination of Escherichia coli pathotypes. J Microbiol Methods 94: 180– 191.

129. Tan KE,, Ellis BC,, Lee R,, Stamper PD,, Zhang SX,, Carroll KC. 2012. Prospective evaluation of a matrix-assisted laser desorption ionization–time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness. J Clin Microbiol 50: 3301– 3308.

130. Jung JS,, Popp C,, Sparbier K,, Lange C,, Kostrzewa M,, Schubert S. 2014. Evaluation of matrix-assisted laser desorption ionization–time of flight mass spectrometry for rapid detection of β-lactam resistance in Enterobacteriaceae derived from blood cultures. J Clin Microbiol 52: 924– 930.

131. Sauget M,, Cabrolier N,, Manzoni M,, Bertrand X,, Hocquet D. 2014. Rapid, sensitive and specific detection of OXA-48-like-producing Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Microbiol Methods 105: 88– 91.

132. Kulkarni MV,, Zurita AN,, Pyka JS,, Murray TS,, Hodsdon ME,, Peaper DR. 2014. Use of imipenem to detect KPC, NDM, OXA, IMP, and VIM carbapenemase activity from Gram-negative rods in 75 minutes using liquid chromatography-tandem mass spectrometry. J Clin Microbiol 52: 2500– 2505.

133. Hrabak J,, Chudackova E,, Walkova R. 2013. Matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosis. Clin Microbiol Rev 26: 103– 114.

134. Bettelheim KA,. 1992. The genus Escherichia, p 2696– 2736. In Balows A,, Truper HG,, Dworkin M,, Harder W,, Schleifer KH ( ed), The Prokaryotes, 2nd ed. Springer-Verlag KG, Berlin, German.

135. Fields PI,, Blom K,, Hughes HJ,, Helsel LO,, Feng P,, Swaminathan B. 1997. Molecular characterization of the gene encoding H antigen in Escherichia coli and development of a PCR-restriction fragment length polymorphism test for identification of E. coli O157:H7 and O157:NM. J Clin Microbiol 35: 1066– 1070.

136. Mignard S,, Flandrois JP. 2006. 16S rRNA sequencing in routine bacterial identification: a 30-month experiment. J Microbiol Methods 67: 574– 581.

137. Simmon KE,, Croft AC,, Petti CA. 2006. Application of SmartGene IDNS software to partial 16S rRNA gene sequences for a diverse group of bacteria in a clinical laboratory. J Clin Microbiol 44: 4400– 4406.

138. Rantakokko-Jalava K,, Nikkari S,, Jalava J,, Eerola E,, Skurnik M,, Meurman O,, Ruuskanen O,, Alanen A,, Kotilainen E,, Toivanen P,, Kotilainen P. 2000. Direct amplification of rRNA genes in diagnosis of bacterial infections. J Clin Microbiol 38: 32– 39.

139. Petti CA,, Polage CR,, Schreckenberger P. 2005. The role of 16S rRNA gene sequencing in identification of microorganisms misidentified by conventional methods. J Clin Microbiol 43: 6123– 6125.

140. Fontana C,, Favaro M,, Pelliccioni M,, Pistoia ES,, Favalli C. 2005. Use of the MicroSeq 500 16S rRNA gene-based sequencing for identification of bacterial isolates that commercial automated systems failed to identify correctly. J Clin Microbiol 43: 615– 619.

141. Woo PC,, Ng KH,, Lau SK,, Yip KT,, Fung AM,, Leung KW,, Tam DM,, Que TL,, Yuen KY. 2003. Usefulness of the MicroSeq 500 16S ribosomal DNA-based bacterial identification system for identification of clinically significant bacterial isolates with ambiguous biochemical profiles. J Clin Microbiol 41: 1996– 2001.

142. Naum M,, Brown EW,, Mason-Gamer RJ. 2008. Is 16S rDNA a reliable phylogenetic marker to characterize relationships below the family level in the Enterobacteriaceae? J Mol Evol 66: 630– 642.

143. Ecker DJ,, Sampath R,, Massire C,, Blyn LB,, Hall TA,, Eshoo MW,, Hofstadler SA. 2008. Ibis T5000: a universal biosensor approach for microbiology. Nat Rev Microbiol 6: 553– 558.

144. Didelot X,, Bowden R,, Wilson DJ,, Peto TE,, Crook DW. 2012. Transforming clinical microbiology with bacterial genome sequencing. Nat Rev Genet 13: 601– 612.

145. Rasko DA,, Webster DR,, Sahl JW,, Bashir A,, Boisen N,, Scheutz F,, Paxinos EE,, Sebra R,, Chin CS,, Iliopoulos D,, Klammer A,, Peluso P,, Lee L,, Kislyuk AO,, Bullard J,, Kasarskis A,, Wang S,, Eid J,, Rank D,, Redman JC,, Steyert SR,, Frimodt-Moller J,, Struve C,, Petersen AM,, Krogfelt KA,, Nataro JP,, Schadt EE,, Waldor MK. 2011. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med 365: 709– 717.

146. Nguyen TV,, Le Van P,, Le Huy C,, Gia KN,, Weintraub A. 2005. Detection and characterization of diarrheagenic Escherichia coli from young children in Hanoi, Vietnam. J Clin Microbiol 43: 755– 760.

147. Scheutz F,, Teel LD,, Beutin L,, Pierard D,, Buvens G,, Karch H,, Mellmann A,, Caprioli A,, Tozzoli R,, Morabito S,, Strockbine NA,, Melton-Celsa AR,, Sanchez M,, Persson S,, O’Brien AD. 2012. Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J Clin Microbiol 50: 2951– 2963.

148. Persson S,, Olsen KE,, Ethelberg S,, Scheutz F. 2007. Subtyping method for Escherichia coli Shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol 45: 2020– 2024.

149. Soborg B,, Lassen SG,, Muller L,, Jensen T,, Ethelberg S,, Molbak K,, Scheutz F. 2013. A verocytotoxin-producing E. coli outbreak with a surprisingly high risk of haemolytic uraemic syndrome, Denmark, September-October 2012. Euro Surveill 18: pii– 20350. http://www.eurosurveil lance.org/ViewArticle.aspx?ArticleId=20350.

150. Bielaszewska M,, Friedrich AW,, Aldick T,, SchurkBulgrin R,, Karch H. 2006. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin Infect Dis 43: 1160– 1167.

151. O’Brien AD,, Holmes RK. 1987. Shiga and Shiga-like toxins. Microbiol Rev 51: 206– 220.

152. Tazzari PL,, Ricci F,, Carnicelli D,, Caprioli A,, Tozzi AE,, Rizzoni G,, Conte R,, Brigotti M. 2004. Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome. Cytometry B Clin Cytom 61: 40– 44.

153. Prager R,, Annemuller S,, Tschape H. 2005. Diversity of virulence patterns among shiga toxin-producing Escherichia coli from human clinical cases—need for more detailed diagnostics. Int J Med Microbiol 295: 29– 38.

154. Wickham ME,, Lupp C,, Mascarenhas M,, Vazquez A,, Coombes BK,, Brown NF,, Coburn BA,, Deng W,, Puente JL,, Karmali MA,, Finlay BB. 2006. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J Infect Dis 194: 819– 827.

155. Karmali MA,, Mascarenhas M,, Shen S,, Ziebell K,, Johnson S,, Reid-Smith R,, Isaac-Renton J,, Clark C,, Rahn K,, Kaper JB. 2003. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol 41: 4930– 4940.

156. Scotland SM,, Willshaw GA,, Said B,, Smith HR,, Rowe B. 1989. Identification of Escherichia coli that produces heat-stable enterotoxin STA by a commercially available enzyme-linked immunoassay and comparison of the assay with infant mouse and DNA probe tests. J Clin Microbiol 27: 1697– 1699.

157. Yam WC,, Lung ML,, Ng MH. 1992. Evaluation and optimization of a latex agglutination assay for detection of cholera toxin and Escherichia coli heat-labile toxin. J Clin Microbiol 30: 2518– 2520.

158. Miqdady MS,, Jiang ZD,, Nataro JP,, DuPont HL. 2002. Detection of enteroaggregative Escherichia coli with formalin-preserved HEp-2 cells. J Clin Microbiol 40: 3066– 3067.

159. Yamamoto T,, Koyama Y,, Matsumoto M,, Sonoda E,, Nakayama S,, Uchimura M,, Paveenkittiporn W,, Tamura K,, Yokota T,, Echeverria P. 1992. Localized, aggregative, and diffuse adherence to HeLa cells, plastic, and human small intestines by Escherichia coli isolated from patients with diarrhea. J Infect Dis 166: 1295– 1310.

160. Albert MJ,, Qadri F,, Haque A,, Bhuiyan NA. 1993. Bacterial clump formation at the surface of liquid culture as a rapid test for identification of enteroaggregative Escherichia coli. J Clin Microbiol 31: 1397– 1399.

161. Baudry B,, Savarino SJ,, Vial P,, Kaper JB,, Levine MM. 1990. A sensitive and specific DNA probe to identify enteroaggregative Escherichia coli, a recently discovered diarrheal pathogen. J Infect Dis 161: 1249– 1251.

162. Nishi J,, Sheikh J,, Mizuguchi K,, Luisi B,, Burland V,, Boutin A,, Rose DJ,, Blattner FR,, Nataro JP. 2003. The export of coat protein from enteroaggregative Escherichia coli by a specific ATP-binding cassette transporter system. J Biol Chem 278: 45680– 45689.

163. Hyytia-Trees E,, Smole SC,, Fields PA,, Swaminathan B,, Ribot EM. 2006. Second generation subtyping: a proposed PulseNet protocol for multiple-locus variable-number tandem repeat analysis of Shiga toxin–producing Escherichia coli O157 (STEC O157). Foodborne Pathog Dis 3: 118– 131.

164. Swaminathan B,, Barrett TJ,, Hunter SB,, Tauxe RV,, CDC PulseNet Task Force. 2001. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg Infect Dis 7: 382– 389.

165. Ludwig K,, Grabhorn E,, Bitzan M,, Bobrowski C,, Kemper MJ,, Sobottka I,, Laufs R,, Karch H,, Muller-Wiefel DE. 2002. Saliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome. Pediatr Res 52: 307– 313.

166. Sjogren AC,, Kaper JB,, Caprioli A,, Karpman D. 2004. Enzyme-linked immunosorbent assay for detection of Shiga toxin-producing Escherichia coli infection by antibodies to Escherichia coli secreted protein B in children with hemolytic uremic syndrome. Eur J Clin Microbiol Infect Dis 23: 208– 211.

167. Doi Y,, Park YS,, Rivera JI,, Adams-Haduch JM,, Hingwe A,, Sordillo EM,, Lewis JS, II,, Howard WJ,, Johnson LE,, Polsky B,, Jorgensen JH,, Richter SS,, Shutt KA,, Paterson DL. 2013. Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis 56: 641– 648.

168. Tadesse DA,, Zhao S,, Tong E,, Ayers S,, Singh A,, Bartholomew MJ,, McDermott PF. 2012. Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950–2002. Emerg Infect Dis 18: 741– 749.

169. Banerjee R,, Johnston B,, Lohse C,, Porter SB,, Clabots C,, Johnson JR. 2013. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol 34: 361– 369.

170. Johnson JR,, Tchesnokova V,, Johnston B,, Clabots C,, Roberts PL,, Billig M,, Riddell K,, Rogers P,, Qin X,, Butler-Wu S,, Price LB,, Aziz M,, Nicolas-Chanoine MH,, Debroy C,, Robicsek A,, Hansen G,, Urban C,, Platell J,, Trott DJ,, Zhanel G,, Weissman SJ,, Cookson BT,, Fang FC,, Limaye AP,, Scholes D,, Chattopadhyay S,, Hooper DC,, Sokurenko EV. 2013. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis 207: 919– 928.

171. Banerjee R,, Robicsek A,, Kuskowski MA,, Porter S,, Johnston BD,, Sokurenko E,, Tchesnokova V,, Price LB,, Johnson JR. 2013. Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago region, 2007 to 2010. Antimicrob Agents Chemother 57: 6385– 6388.

172. Jacoby GA. 2009. AmpC β-lactamases. Clin Microbiol Rev 22: 161– 182.

173. Anderson KF,, Lonsway DR,, Rasheed JK,, Biddle J,, Jensen B,, McDougal LK,, Carey RB,, Thompson A,, Stocker S,, Limbago B,, Patel JB. 2007. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 45: 2723– 2725.

174. Clinical and Laboratory Standards Institute . 2014. Performance Standards for Antimicrobial Susceptibility Testing; 24th Informational Supplement. CLSI Document M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.

175. Fisher MA,, Stamper PD,, Hujer KM,, Love Z,, Croft A,, Cohen S,, Bonomo RA,, Carroll KC,, Petti CA. 2009. Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum β-lactamase, AmpC and KPC producers. J Med Microbiol 58: 774– 778.

176. Sanders CC,, Peyret M,, Moland ES,, Shubert C,, Thomson KS,, Boeufgras JM,, Sanders WE, Jr. 2000. Ability of the VITEK 2 Advanced Expert System to identify β-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol 38: 570– 574.

177. Thomson KS. 2010. Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues. J Clin Microbiol 48: 1019– 1025.

178. Clinical and Laboratory Standards Institute . 2010. Performance Standards for Antimicrobial Susceptibility Testing; 20th Information Supplement. CLSI Document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.

179. Clark RB,, Lewinski MA,, Loeffelholz MJ,, Tibbetts RJ,. 2009. Cumitech 31A: Verification and Validation of Procedures in Clinical Microbiology Laboratory. Coordinating ed, Sharp SE. ASM Press, Washington, DC.

180. Wong CS,, Jelacic S,, Habeeb RL,, Watkins SL,, Tarr PI. 2000. The risk of hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342: 1930– 1936.

181. Safdar N. 2002. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis. JAMA 288: 996– 1001.

182. Glandt M,, Adachi JA,, Mathewson JJ,, Jiang ZD,, DiCesare D,, Ashley D,, Ericsson CD,, DuPont HL. 1999. Enteroaggregative Escherichia coli as a cause of traveler’s diarrhea: clinical response to ciprofloxacin. Clin Infect Dis 29: 335– 338.

183. Lan R,, Alles MC,, Donohoe K,, Martinez MB,, Reeves PR. 2004. Molecular evolutionary relationships of enteroinvasive Escherichia coli and Shigella spp. Infect Immun 72: 5080– 5088.

184. Brenner DJ,, Fanning GR,, Skerman FJ,, Falkow S. 1972. Polynucleotide sequence divergence among strains of Escherichia coli and closely related organisms. J Bacteriol 109: 953– 965.

185. Brenner DJ,, Fanning GR,, Miklos GV,, Steigerwalt AG. 1973. Polynucleotide sequence relatedness among Shigella species. Int J Syst Bacteriol 23: 1– 7.

186. Ewing WH,, Reavis RW,, Davis BR. 1958. Provisional Shigella serotypes. Can J Microbiol 4: 89– 107.

187. Strockbine NA,, Maurelli AT,. 2005. Genus XXXV. Shigella Castellani and Chalmers 1919, 936 AL, p 811– 823. In Garrity GM,, Brenner DJ,, Krieg NR,, Staley JT ( ed), Bergey’s Manual of Systematic Bacteriology, 2nd ed, vol 2, part B. Springer-Verlag, New York, NY.

188. Ewing WH. 1986. Edwards and Ewing’s Identification of Enterobacteriaceae, 4th ed, p 135– 172. Elsevier Science Publishing Co, Inc, New York, NY.

189. von Seidlein L,, Kim DR,, Ali M,, Lee H,, Wang X,, Thiem VD,, Canh do G,, Chaicumpa W,, Agtini MD,, Hossain A,, Bhutta ZA,, Mason C,, Sethabutr O,, Talukder K,, Nair GB,, Deen JL,, Kotloff K,, Clemens J. 2006. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med 3: e353. doi:10.1371/journal.pmed.0030353.

190. Brooks JT,, Ochieng JB,, Kumar L,, Okoth G,, Shapiro RL,, Wells JG,, Bird M,, Bopp C,, Chege W,, Beatty ME,, Chiller T,, Vulule JM,, Mintz E,, Slutsker L. 2006. Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997–2003. Clin Infect Dis 43: 393– 401.

191. Kuo CY,, Su LH,, Perera J,, Carlos C,, Tan BH,, Kumarasinghe G,, So T,, Van PH,, Chongthaleong A,, Song JH,, Chiu CH. 2008. Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001–2004. J Microbiol Immunol Infect 41: 107– 111.

192. Centers for Disease Control and Prevention (CDC) . 2004. Day care–related outbreaks of rhamnose-negative Shigella sonnei—six states, June 2001–March 2003. MMWR Morb Mortal Wkly Rep 53: 60– 63.

193. Centers for Disease Control and Prevention (CDC) . 2006. Outbreaks of multidrug-resistant Shigella sonnei gastroenteritis associated with day care centers—Kansas, Kentucky, and Missouri, 2005. MMWR Morb Mortal Wkly Rep 55: 1068– 1071.

194. Arvelo W,, Hinkle CJ,, Nguyen TA,, Weiser T,, Stein-muller N,, Khan F,, Gladbach S,, Parsons M,, Jennings D,, Zhu BP,, Mintz E,, Bowen A. 2009. Transmission risk factors and treatment of pediatric shigellosis during a large daycare center-associated outbreak of multidrug resistant Shigella sonnei: implications for the management of shigellosis outbreaks among children. Pediatr Infect Dis J 28: 976– 980.

195. Centers for Disease Control and Prevention (CDC) . 2001. Shigella sonnei outbreak among men who have sex with men—San Francisco, California, 2000–2001. MMWR Morb Mortal Wkly Rep 50: 922– 926.

196. Daskalakis DC,, Blaser MJ. 2007. Another perfect storm: Shigella, men who have sex with men, and HIV. Clin Infect Dis 44: 335– 337.

197. Guerrero L,, Calva JJ,, Morrow AL,, Velazquez FR,, Tuz-Dzib F,, Lopez-Vidal Y,, Ortega H,, Arroyo H,, Cleary TG,, Pickering LK. 1994. Asymptomatic Shigella infections in a cohort of Mexican children younger than two years of age. Pediatr Infect Dis J 13: 597– 602.

198. Lolekha S,, Vibulbandhitkit S,, Poonyarit P. 1991. Response to antimicrobial therapy for shigellosis in Thailand. Rev Infect Dis 13( Suppl 4): S342– S346.

199. Sjolund Karlsson M,, Bowen A,, Reporter R,, Folster JP,, Grass JE,, Howie RL,, Taylor J,, Whichard JM. 2013. Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States. Antimicrob Agents Chemother 57: 1559– 1560.

200. Acheson DWK,, Keusch GT,. 1995. Shigella and enteroinvasive Escherichia coli, p 763– 784. In Blaser MJ,, Smith PD,, Ravdin JI,, Greenberg HB,, Guerrant RL ( ed), Infections of the Gastrointestinal Tract. Raven Press, New York, NY.

201. Strockbine NA,, Parsonnet J,, Greene K,, Kiehlbauch JA,, Wachsmuth IK. 1991. Molecular epidemiologic techniques in analysis of epidemic and endemic Shigella dysenteriae type 1 strains. J Infect Dis 163: 406– 409.

202. Sangal V,, Holt KE,, Yuan J,, Brown DJ,, Filliol-Toutain I,, Weill FX,, Kim DW,, da Silveira WD,, Pickard D,, Thomson NR,, Parkhill J,, Yu J. 2013. Global phylogeny of Shigella sonnei strains from limited single nucleotide polymorphisms (SNPs) and development of a rapid and cost-effective SNP-typing scheme for strain identification by high-resolution melting analysis. J Clin Microbiol 51: 303– 305.

203. Gorge O,, Lopez S,, Hilaire V,, Lisanti O,, Ramisse V,, Vergnaud G. 2008. Selection and validation of a multilocus variable-number tandem-repeat analysis panel for typing Shigella spp. J Clin Microbiol 46: 1026– 1036.

204. Lindberg AA,, Cam PD,, Chan N,, Phu LK,, Trach DD,, Lindberg G,, Karlsson K,, Karnell A,, Ekwall E. 1991. Shigellosis in Vietnam: seroepidemiologic studies with use of lipopolysaccharide antigens in enzyme immunoassays. Rev Infect Dis 13( Suppl 4): S231– S237.

205. Verbrugh HA,, Mekkes DR,, Verkooyen RP,, Landheer JE. 1987. Widal-type serology using live antigen for diagnosis of Shigella flexneri dysentery. Eur J Clin Microbiol 5: 540– 542.

206. Clinical and Laboratory Standards Institute . 2013. Performance Standards for Antimicrobial Susceptibility Testing; 23rd Informational Supplement. CLSI Document M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.

207. Tauxe RV,, Puhr ND,, Wells JG,, Hargrett-Bean N,, Blake PA. 1990. Antimicrobial resistance of Shigella isolates in the USA: the importance of international travelers. J Infect Dis 162: 1107– 1111.

208. Sack RB,, Rahman M,, Yunus M,, Khan EH. 1997. Antimicrobial resistance in organisms causing diarrheal disease. Clin Infect Dis 24( Suppl 1): S102– S105.

209. Taneja N. 2007. Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant shigellae in India. J Clin Microbiol 45: 678– 679.

210. Talukder KA,, Khajanchi BK,, Islam MA,, Dutta DK,, Islam Z,, Safa A,, Khan GY,, Alam K,, Hossain MA,, Malla S,, Niyogi SK,, Rahman M,, Watanabe H,, Nair GB,, Sack DA. 2004. Genetic relatedness of ciprofloxacin-resistant Shigella dysenteriae type 1 strains isolated in south Asia. J Antimicrob Chemother 54: 730– 734.

211. Popoff MY,, Le Minor LE,. 2005. Genus XXXIII. Salmonella Lignieres 1900, 389 AL, p 764– 799. In Garrity GM,, Brenner DJ,, Krieg NR,, Staley JT ( ed), Bergey’s Manual of Systematic Bacteriology, 2nd ed, vol 2, part B. Springer-Verlag, New York, NY.

212. Tindall BJ,, Grimont PA,, Garrity GM,, Euzeby JP. 2005. Nomenclature and taxonomy of the genus Salmonella. Int J Syst Evol Microbiol 55: 521– 524.

213. Judicial Commission of the International Committee on Systematics of Prokaryotes . 2005. The type species of the genus Salmonella Lignieres 1900 is Salmonella enterica ( ex Kauffmann and Edwards 1952) Le Minor and Popoff 1987, with the type strain LT2 T, and conservation of the epithet enterica in Salmonella enterica over all earlier epithets that may be applied to this species. Opinion 80. Int J Syst Evol Microbiol 55: 519– 520.

214. Rohde R. 1979. [Serological integration of all known Arizona species into the Kauffmann-White scheme]. Zentralbl Bakteriol Orig A 243: 148– 176. (In German.)

215. McQuiston JR,, Herrera-Leon S,, Wertheim BC,, Doyle J,, Fields PI,, Tauxe RV,, Logsdon JM, Jr. 2008. Molecular phylogeny of the salmonellae: relationships among Salmonella species and subspecies determined from four housekeeping genes and evidence of lateral gene transfer events. J Bacteriol 190: 7060– 7067.

216. Desai PT,, Porwollik S,, Long F,, Cheng P,, Wollam A,, Bhonagiri-Palsikar V,, Hallsworth-Pepin K,, Clifton SW,, Weinstock GM,, McClelland M. 2013. Evolutionary genomics of Salmonella enterica subspecies. mBio 4: e00579– 12. 10.1128/mBio.00579-12.

217. Porwollik S,, McClelland M. 2007. Determination of the gene content of Salmonella genomes by microarray analysis. Methods Mol Biol 394: 89– 103.

218. Edwards RA,, Olsen GJ,, Maloy SR. 2002. Comparative genomics of closely related salmonellae. Trends Microbiol 10: 94– 99.

219. Lan R,, Reeves PR,, Octavia S. 2009. Population structure, origins and evolution of major Salmonella enterica clones. Infect Genet Evol 9: 996– 1005.

220. den Bakker HC,, Moreno Switt AI,, Govoni G,, Cummings CA,, Ranieri ML,, Degoricija L,, Hoelzer K,, Rodriguez-Rivera LD,, Brown S,, Bolchacova E,, Furtado MR,, Wiedmann M. 2011. Genome sequencing reveals diversification of virulence factor content and possible host adaptation in distinct subpopulations of Salmonella enterica. BMC Genomics 12: 425. doi:10.1186/1471-2164-12-425.

221. Timme RE,, Pettengill J,, Allard MW,, Strain E,, Barrangou R,, Wehnes C,, Kessel JV,, Karns J,, Musser SM,, Brown EW. 2013. Phylogenetic diversity of the enteric pathogen Salmonella enterica subsp. enterica inferred from genome-wide reference-free SNP characters. Genome Biol Evol 5: 2109– 2123.

222. Leekitcharoenphon P,, Lukjancenko O,, Friis C,, Aarestrup FM,, Ussery DW. 2012. Genomic variation in Salmonella enterica core genes for epidemiological typing. BMC Genomics 13: 88. doi:10.1186/1471-2164-13-88.

223. Allard MW,, Luo Y,, Strain E,, Pettengill J,, Timme R,, Wang C,, Li C,, Keys CE,, Zheng J,, Stones R,, Wilson MR,, Musser SM,, Brown EW. 2013. On the evolutionary history, population genetics and diversity among isolates of Salmonella Enteritidis PFGE pattern JEGX01.0004. PLoS One 8: e55254. doi:10.1371/journal.pone.0055254.

224. Hanning IB,, Nutt JD,, Ricke SC. 2009. Salmonellosis outbreaks in the United States due to fresh produce: sources and potential intervention measures. Foodborne Pathog Dis 6: 635– 648.

225. Kendall ME,, Mody RK,, Mahon BE,, Doyle MP,, Herman KM,, Tauxe RV. 2013. Emergence of salsa and guacamole as frequent vehicles of foodborne disease outbreaks in the United States, 1973–2008. Foodborne Pathog Dis 10: 316– 322.

226. Cavallaro E,, Date K,, Medus C,, Meyer S,, Miller B,, Kim C,, Nowicki S,, Cosgrove S,, Sweat D,, Phan Q,, Flint J,, Daly ER,, Adams J,, Hyytia-Trees E,, Gerner-Smidt P,, Hoekstra RM,, Schwensohn C,, Langer A,, Sodha SV,, Rogers MC,, Angulo FJ,, Tauxe RV,, Williams IT,, Behravesh CB, Salmonella Typhimurium Outbreak Investigation Team . 2011. Salmonella Typhimurium infections associated with peanut products. N Engl J Med 365: 601– 610.

227. Gerner-Smidt P,, Hise K,, Kincaid J,, Hunter S,, Rolando S,, Hyytia-Trees E,, Ribot EM,, Swaminathan B,, Pulsenet T. 2006. PulseNet USA: a five-year update. Foodborne Pathog Dis 3: 9– 19.

228. Nadon CA,, Trees E,, Ng LK,, Moller Nielsen E,, Reimer A,, Maxwell N,, Kubota KA,, Gerner-Smidt P,, MLVA Harmonization Working Group. 2013. Development and application of MLVA methods as a tool for inter-laboratory surveillance. Euro Surveill 18: pii= 20565. http://www.euro surveillance.org/ViewArticle.aspx?ArticleId=20565.

229. Rebolledo J,, Garvey P,, Ryan A,, O’Donnell J,, Cormican M,, Jackson S,, Cloak F,, Cullen L,, Swaan CM,, Schimmer B,, Appels RW,, Nygard K,, Finley R,, Sreenivasan N,, Lenglet A,, Gossner C,, McKeown P. 2013. International outbreak investigation of Salmonella Heidelberg associated with in-flight catering. Epidemiol Infect 142: 833– 842.

230. Hohmann EL. 2001. Nontyphoidal salmonellosis. Clin Infect Dis 32: 263– 269.

231. Prager R,, Rabsch W,, Streckel W,, Voigt W,, Tietze E,, Tschape H. 2003. Molecular properties of Salmonella enterica serotype Paratyphi B distinguish between its systemic and its enteric pathovars. J Clin Microbiol 41: 4270– 4278.

232. Vugia DJ,, Samuel M,, Farley MM,, Marcus R,, Shiferaw B,, Shallow S,, Smith K,, Angulo FJ, Emerging Infections Program FoodNet Working Group . 2004. Invasive Salmonella infections in the United States, FoodNet, 1996–1999: incidence, serotype distribution, and outcome. Clin Infect Dis 38( Suppl 3): S149– S156.

233. Bouvet PJ,, Jeanjean S. 1992. Evaluation of two colored latex kits, the Wellcolex Colour Salmonella Test and the Wellcolex Colour Shigella Test, for serological grouping of Salmonella and Shigella species. J Clin Microbiol 30: 2184– 2186.

234. Martiny D,, Busson L,, Wybo I,, El Haj RA,, Dediste A,, Vandenberg O. 2012. Comparison of the Microflex LT and Vitek MS systems for routine identification of bacteria by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol 50: 1313– 1325.

235. Sparbier K,, Weller U,, Boogen C,, Kostrzewa M. 2012. Rapid detection of Salmonella sp. by means of a combination of selective enrichment broth and MALDI-TOF MS. Eur J Clin Microbiol Infect Dis 31: 767– 773.

236. Kuhns M,, Zautner AE,, Rabsch W,, Zimmermann O,, Weig M,, Bader O,, Gross U. 2012. Rapid discrimination of Salmonella enterica serovar Typhi from other serovars by MALDI-TOF mass spectrometry. PLoS One 7: e40004. 10.1371/journal.pone.0040004.

237. Dieckmann R,, Malorny B. 2011. Rapid screening of epidemiologically important Salmonella enterica subsp. enterica serovars by whole-cell matrix-assisted laser desorption ionization–time of flight mass spectrometry. Appl Environ Microbiol 77: 4136– 4146.

238. Brenner FW,, McWhorter-Murlin AC. 1998. Identification and Serotyping of Salmonella. Centers for Disease Control and Prevention, Atlanta, GA.

239. Grimont PAD,, Weill FX. 2007. Antigenic Formulae of the Salmonella Serovars, 9th ed. WHO Collaborating Centre for Reference and Research on Salmonella, Institut Pasteur, Paris, France.

240. Wattiau P,, Boland C,, Bertrand S. 2011. Methodologies for Salmonella enterica subsp. enterica subtyping: gold standards and alternatives. Appl Environ Microbiol 77: 7877– 7885.

241. Boxrud D,, Pederson-Gulrud K,, Wotton J,, Medus C,, Lyszkowicz E,, Besser J,, Bartkus JM. 2007. Comparison of multiple-locus variable-number tandem repeat analysis, pulsed-field gel electrophoresis, and phage typing for subtype analysis of Salmonella enterica serotype Enteritidis. J Clin Microbiol 45: 536– 543.

242. Olsen SJ,, Pruckler J,, Bibb W,, Nguyen TM,, Tran MT,, Sivapalasingam S,, Gupta A,, Phan TP,, Nguyen TC,, Nguyen VC,, Phung DC,, Mintz ED. 2004. Evaluation of rapid diagnostic tests for typhoid fever. J Clin Microbiol 42: 1885– 1889.

243. Lee LA,, Puhr ND,, Maloney EK,, Bean NH,, Tauxe RV. 1994. Increase in antimicrobial-resistant Salmonella infections in the United States, 1989–1990. J Infect Dis 170: 128– 134.

244. Kadhiravan T,, Wig N,, Kapil A,, Kabra SK,, Renuka K,, Misra A. 2005. Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. BMC Infect Dis 5: 37. 10.1186/1471-2334-5-37.

245. Rahman MM,, Haq JA,, Morshed MA,, Rahman MA. 2005. Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin—an emerging problem in Bangladesh. Int J Antimicrob Agents 25: 345– 346.

246. Centers for Disease Control and Prevention . 2013. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2011. CDC, Atlanta, GA. http://stacks.cdc.gov/view/cdc/23525.

247. Ewing WH, , et al . 1971. Biochemical Reactions of Shigella. Public Health Service Publication 72-8081. Centers for Disease Control, U.S. Department of Health, Education, and Welfare, Atlanta, GA.

248. Wathen-Grady HG,, Davis BR,, Morris GK. 1985. Addition of three new serotypes of Shigella boydii to the Shigella schema. J Clin Microbiol 21: 129– 132.

249. Wathen-Grady HG,, Britt LE,, Strockbine NA,, Wachsmuth IK. 1990. Characterization of Shigella dysenteriae serotypes 11, 12, and 13. J Clin Microbiol 28: 2580– 2584.

250. Ansaruzzaman M,, Kibriya AK,, Rahman A,, Neogi PK,, Faruque AS,, Rowe B,, Albert MJ. 1995. Detection of provisional serovars of Shigella dysenteriae and designation as S. dysenteriae serotypes 14 and 15. J Clin Microbiol 33: 1423– 1425.

251. Pryamukhina NS,, Khomenko NA. 1988. Suggestion to supplement Shigella flexneri classification scheme with the subserovar Shigella flexneri 4c: phenotypic characteristics of strains. J Clin Microbiol 26: 1147– 1149.

252. Farmer JJI,. 2003. Enterobacteriaceae: introduction and identification, p 636– 653. In Murray PR,, Baron EJ,, Jorgensen JH,, Pfaller MA,, Yolken RH ( ed), Manual of Clinical Microbiology, 8th ed, vol 1. ASM Press, Washington, DC.

253. Buchholz U,, Bernard H,, Werber D,, Bohmer MM,, Remschmidt C,, Wilking H,, Delere Y,, an der Heiden M,, Adlhoch C,, Dreesman J,, Ehlers J,, Ethelberg S,, Faber M,, Frank C,, Fricke G,, Greiner M,, Hohle M,, Ivarsson S,, Jark U,, Kirchner M,, Koch J,, Krause G,, Luber P,, Rosner B,, Stark K,, Kuhne M. 2011. German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med 365: 1763– 1770.

254. Morabito S,, Karch H,, Mariani-Kurkdjian P,, Schmidt H,, Minelli F,, Bingen E,, Caprioli A. 1998. Enteroaggregative, Shiga toxin-producing Escherichia coli O111:H2 associated with an outbreak of hemolytic-uremic syndrome. J Clin Microbiol 36: 840– 842.

Tables

Escherichia, Shigella, andSalmonella

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817381.mcm11.ch37-1,webId=/content/author/10.1128/9781555817381.mcm11.ch37-1,properties={foaf_givenname=Nancy A., foaf_name=Nancy A. Strockbine, foaf_surname=Strockbine}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817381.mcm11.ch37-2,webId=/content/author/10.1128/9781555817381.mcm11.ch37-2,properties={foaf_givenname=Cheryl A., foaf_name=Cheryl A. Bopp, foaf_surname=Bopp}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817381.mcm11.ch37-3,webId=/content/author/10.1128/9781555817381.mcm11.ch37-3,properties={foaf_givenname=Patricia I., foaf_name=Patricia I. Fields, foaf_surname=Fields}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817381.mcm11.ch37-4,webId=/content/author/10.1128/9781555817381.mcm11.ch37-4,properties={foaf_givenname=JAMES B., foaf_name=JAMES B. Kaper, foaf_surname=Kaper}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817381.mcm11.ch37-5,webId=/content/author/10.1128/9781555817381.mcm11.ch37-5,properties={foaf_givenname=James P., foaf_name=James P. Nataro, foaf_surname=Nataro}]]

/content/10.1128/9781555817381.mcm11.ch37.ch37.tab001

TABLE 1

Biochemical reactions of the six species of Escherichia and selected members of the family Enterobacteriaceae a

TABLE 1

Biochemical reactions of the six species of Escherichia and selected members of the family Enterobacteriaceae a

/content/10.1128/9781555817381.mcm11.ch37.ch37.tab002

TABLE 2

Frequently encountered serotypes of diarrheagenic E. coli a

TABLE 2

Frequently encountered serotypes of diarrheagenic E. coli a

/content/10.1128/9781555817381.mcm11.ch37.ch37.tab003

TABLE 3

Partial listing of commercial suppliers of reagents for detection of STEC a

TABLE 3

Partial listing of commercial suppliers of reagents for detection of STEC a

/content/10.1128/9781555817381.mcm11.ch37.ch37.tab004

TABLE 4

Differentiation of E. coli and Shigella

TABLE 4

Differentiation of E. coli and Shigella

/content/10.1128/9781555817381.mcm11.ch37.ch37.tab005

TABLE 5

Phenotypic traits useful for differentiating Salmonella from other Enterobacteriaceae and identifying Salmonella serotypes Typhi and Paratyphi A a

TABLE 5

Phenotypic traits useful for differentiating Salmonella from other Enterobacteriaceae and identifying Salmonella serotypes Typhi and Paratyphi A a

/content/10.1128/9781555817381.mcm11.ch37.ch37.tab006

TABLE 6

Phenotypic traits useful for differentiating Salmonella species and subspecies a

TABLE 6

Phenotypic traits useful for differentiating Salmonella species and subspecies a